Operating Expenses - MaxCyte Inc (NASDAQ:MXCT) - Alpha Spread
M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 4.06 USD -0.98% Market Closed
Market Cap: 425.6m USD
Have any thoughts about
MaxCyte Inc?
Write Note

MaxCyte Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MaxCyte Inc
Operating Expenses Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
M
MaxCyte Inc
NASDAQ:MXCT
Operating Expenses
-$84.8m
CAGR 3-Years
-35%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Operating Expenses
-$9.8B
CAGR 3-Years
-4%
CAGR 5-Years
-7%
CAGR 10-Years
-8%
Danaher Corp
NYSE:DHR
Operating Expenses
-$8.5B
CAGR 3-Years
2%
CAGR 5-Years
-8%
CAGR 10-Years
-3%
Mettler-Toledo International Inc
NYSE:MTD
Operating Expenses
-$1.2B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
Agilent Technologies Inc
NYSE:A
Operating Expenses
-$2B
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
-11%
IQVIA Holdings Inc
NYSE:IQV
Operating Expenses
-$3.2B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
-14%

See Also

What is MaxCyte Inc's Operating Expenses?
Operating Expenses
-84.8m USD

Based on the financial report for Dec 31, 2023, MaxCyte Inc's Operating Expenses amounts to -84.8m USD.

What is MaxCyte Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-30%

Over the last year, the Operating Expenses growth was -28%. The average annual Operating Expenses growth rates for MaxCyte Inc have been -35% over the past three years , -30% over the past five years .

Back to Top